
Decision Scientist | RWE Data Analyst
Mu Sigma · Oct 2022 – Present
- Support Real-World Evidence (RWE) studies for pharmaceutical clients using claims and EHR/EMR data across oncology indications including NSCLC, breast cancer, multiple myeloma, gastric cancer, and melanoma.
- Conduct analyses covering patient characteristics, clinical characteristics, biomarkers, treatment patterns, comorbidities, adverse events, incidence, and survival outcomes.
- Apply Kaplan-Meier, Cox proportional hazards, propensity score matching (PSM), and IPTW for survival and comparative effectiveness analyses.
- Develop and evaluate patient identification and cohort algorithms using claim-based diagnosis and treatment information, including NSCLC and HR+/HER2- breast cancer populations.
- Lead a pod focused on phenotype evaluation using OMOP CDM, working with client-developed ATLAS cohorts and evaluating phenotype performance across multiple databases using established evaluation workflows.
- Collaborate with clients and cross-functional teams to understand study objectives, translate requirements into analytical approaches, and deliver high-quality RWE outputs.


